Wen‐Shan Li

2.7k citations
81 papers · 2.2k indexed · h-index 28
Topics
Glycosylation and Glycoproteins Research (13 papers)Peptidase Inhibition and Analysis (13 papers)Cancer therapeutics and mechanisms (7 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Wen‐Shan Li

79 papers receiving 2.1k citations

Peers

Wen‐Shan Li
Comparison fields: 5 of 131
  • Molecular Biology 817
  • Organic Chemistry 634
  • Materials Chemistry 419
  • Oncology 318
  • Electrical and Electronic Engineering 274
Replace Michael F. Rohde with:
Michael F. Rohde United States
Francesco Musiani Italy
Henning J. Jessen Germany
Marc Devocelle Ireland
Guoying Chen China
Marilisa Leone Italy
Youngjoo Byun South Korea
V. Calderone Italy
W. Kruizinga Netherlands
Keizo Takeshita Japan
Wen‐Shan Li relative to Michael F. Rohde United States Michael F. Rohde's profile →
Citations per field
00.5×4.5×
Michael F. Rohde · 1×
Citations per year

Countries citing papers authored by Wen‐Shan Li

Since Specialization
Citations

This map shows the geographic impact of Wen‐Shan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Shan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Shan Li more than expected).

Fields of papers citing papers by Wen‐Shan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Shan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Shan Li. The network helps show where Wen‐Shan Li may publish in the future.

Co-authorship network of co-authors of Wen‐Shan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Shan Li. A scholar is included among the top collaborators of Wen‐Shan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Shan Li. Wen‐Shan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 6
4 4
5 34
6 3
7 10
8 94
9 48
10 22
11 20
12 2
13 17
14 30
15 115
16 28
17 11
18 6
19 12
20 14

About Wen‐Shan Li

Wen‐Shan Li is a scholar working on Organic Chemistry, Biotechnology and Toxicology, having authored 81 papers that have together received 2.2k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (13 papers), Peptidase Inhibition and Analysis (13 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Organic Chemistry (634 citations), Biotechnology (119 citations) and Pollution (137 citations). Wen‐Shan Li has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Frank M. Raushel, Chie‐Hong Wang, Wen‐Chun Hung, Shivaji V. More, Lawrence M. Sayre, Shu‐Chuan Jao, Craig Hill, Hui–Ming Cheng, Shiyong Zhao and Chang Liu. Their work appears in journals such as Journal of the American Chemical Society, ACS Nano and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026